BioSpace News Archive

Drug Development

Viatris Reports Strong Financial and Operational Results for First Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]

Viatris Inc. (NASDAQ: VTRS) today reported strong results for the first quarter of 2023 reflecting another robust operational performance and instilling further confidence in the Company’s ability to return to growth as it prepares to enter Phase 2 of its strategic plan in 2024.

May 8, 2023
·
34 min read
Biotech Beach

Genome Insight Launches in the U.S. with Innovative Whole Genome Sequencing Approach that Offers Unprecedented, Actionable Insights in Cancer Care

Genome Insight announced today the U.S. launch of CancerVision, their innovative whole genome sequencing (WGS) test designed to provide accurate, timely and medically meaningful insights that collectively guide personalized healthcare decisions.

May 8, 2023
·
4 min read
Business

Seres Therapeutics and Nestlé Health Science Present Results from ECOSPOR IV Phase 3 Study of VOWST™

Seres Therapeutics and Nestlé Health Science Present Results from ECOSPOR IV Phase 3 Study of VOWST™, a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection, at the Digestive Disease Week (DDW) Annual Meeting.

May 8, 2023
·
10 min read
Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023

Mallinckrodt plc, a global specialty pharmaceutical company, announced the presentation of results from two clinical studies for adults with hepatorenal syndrome with rapid reduction in kidney function1 treated with TERLIVAZ® for injection at Digestive Disease Week® 2023, taking place in Chicago, Ill.

May 8, 2023
·
14 min read
Business

ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

ANI Pharmaceuticals, Inc. announced business highlights and financial results for the three months ended March 31, 2023.

May 8, 2023
·
27 min read
BioForest

Athira Pharma to Participate in Upcoming May 2023 Investor Conferences

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, announced that it will participate in the following upcoming investor conferences.

May 8, 2023
·
1 min read
Lone Star Bio

Aravive to Host Virtual KOL Event on its Late-Stage Oncology Asset Batiraxcept

Aravive, Inc., a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, announced it will host a virtual Key Opinion Leader event on its late-stage oncology asset, batiraxcept, on Wednesday, May 24, 2023 at 1:00pm ET.

May 8, 2023
·
3 min read
Business

Tonix Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2023, and provided an overview of recent operational highlights.

May 8, 2023
·
17 min read
Business

Augmedix to Announce First Quarter 2023 Financial Results and Host Investor Conference Call on May 12, 2023

Augmedix Inc. (Nasdaq: AUGX) today announced it will report financial results for the first quarter ended March 31, 2023, on Friday, May 12, 2023, before the market opens.

May 8, 2023
·
1 min read
Job Trends

Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they will present updated data related to vepdegestrant (ARV-471) at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress.

May 8, 2023
·
9 min read